{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01626677",
      "nctIdAliases": [
        "NCT01923532"
      ],
      "orgStudyIdInfo": {
        "id": "CARTISTEM_CR_F/U"
      },
      "organization": {
        "fullName": "Medipost Co Ltd.",
        "class": "INDUSTRY"
      },
      "briefTitle": "Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
      "officialTitle": "Long Term Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee"
    },
    "statusModule": {
      "statusVerifiedDate": "2017-04",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2012-06"
      },
      "primaryCompletionDateStruct": {
        "date": "2015-05",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2015-05",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2012-06-19",
      "studyFirstSubmitQcDate": "2012-06-20",
      "studyFirstPostDateStruct": {
        "date": "2012-06-25",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2017-04-19",
      "lastUpdatePostDateStruct": {
        "date": "2017-04-20",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Medipost Co Ltd.",
        "class": "INDUSTRY"
      },
      "collaborators": [
        {
          "name": "Dong-A Pharmaceutical Co., Ltd.",
          "class": "INDUSTRY"
        }
      ]
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "This is a long term follow-up study to investigate the safety and efficacy of CARTISTEM®, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects who participated in and completed the Phase III trial (NCT01041001) will be tracked until the 60 month post-treatment timepoint.",
      "detailedDescription": "This long term follow-up study is performed to assess the long-term safety and efficacy of CARTISTEM®, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects, who were either administered CARTISTEM or treated with conventional microfracture in the primary phase III study (NCT01041001), will be further observed using various subjective knee assessments and MRI T2 mapping until the 60 month post-treatment timepoint."
    },
    "conditionsModule": {
      "conditions": [
        "Degenerative Osteoarthritis",
        "Defect of Articular Cartilage"
      ],
      "keywords": [
        "Umbilical Cord Blood",
        "Mesenchymal Stem Cells",
        "Cartilage injury",
        "Osteoarthritis"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 103,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "CARTISTEM",
          "type": "EXPERIMENTAL",
          "description": "A single dose of 500㎕/㎠ of cartilage defect",
          "interventionNames": [
            "Biological: CARTISTEM"
          ]
        },
        {
          "label": "Microfracture",
          "type": "ACTIVE_COMPARATOR",
          "description": "conventional treatment method",
          "interventionNames": [
            "Procedure: Microfracture"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "CARTISTEM",
          "description": "A single dose of 500㎕/㎠ of cartilage defect",
          "armGroupLabels": [
            "CARTISTEM"
          ],
          "otherNames": [
            "hUCB-MSCs"
          ]
        },
        {
          "type": "PROCEDURE",
          "name": "Microfracture",
          "description": "Active control",
          "armGroupLabels": [
            "Microfracture"
          ],
          "otherNames": [
            "Conventional surgical treatment"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Degree of improvement in knee assessments compared to the active control (microfracture)",
          "description": "Knee assessments will be performed using the following tools:\n\n* IKDC (International Knee Documentation Committee)\n* Pain score on VAS (Visual Analogue Scale)\n* WOMAC (Western Ontario and McMaster Universities Arthritis Index)",
          "timeFrame": "36 months, 48 months, and 60 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Number of subjects with adverse events",
          "description": "Systemic and local adverse events especially attributable to the implanted cells will be assessed.\n\n* General physical examinations: vital signs, blood tests\n* Physical assessments of the knee: swelling, tenderness, pain, range of motion\n* Tumor formation at the implantation site: radiological evaluation using MRI(T1(dGEMRIC)and T2 mapping)",
          "timeFrame": "36 months, 48 months, and 60 months"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with knee joint cartilage defect or injury of ICRS (International Cartilage Repair Society) Grade 4 confirmed by arthroscopy (At screening, patients diagnosed as such with an MRI may be included)\n* Male or female patients at least 18 years of age\n* Patients whose lesion (unilateral joint) is 2 ㎠ \\~ 9㎠ in size\n* Patients with articular swelling, tenderness and active range of motion of Grade 2 or below\n* Patients with pain in affected joint of 60-mm or below on a 100-mm VAS (visual analogue scale)\n* Patients with adequate blood coagulation activity: PT(INR) \\< 1.5, APTT \\<1.5×control\n* Patients with adequate renal function: Creatinine ≤ 2.0 ㎎/㎗, levels of proteinuria measured with Dipstick: trace or less\n* Patients with adequate hepatic function: Bilirubin ≤ 2.0 ㎎/㎗, AST/ALT ≤ 100 IU/L\n* Patients who have received no surgery or radiation therapy in the affected joint within the past 6 six weeks, and have recovered from the side effects of such past treatments\n* Female patients of childbearing potential must agree to practice adequate methods of birth control to prevent pregnancy during the study\n* Patients whose physical examination results show no ligament instability of Grade II or above (Grade 0: none, Grade I: 0-5 mm, Grade II: 5-10 mm, Grade III: \\>10 mm)\n* Patients who voluntarily agreed to enroll in the study and signed an informed consent form\n\nExclusion Criteria:\n\n* Patients with autoimmune disease or the medical history\n* Patients with infections requiring parenteral administration of antibiotics\n* Patients with myocardial infarction, ischemic heart failure, other serious heart conditions or uncontrolled hypertension, or any medical history of such diseases\n* Patients with serious internal diseases\n* Patients who are currently pregnant or nursing\n* Patients with psychotic diseases, epilepsy, or any history of such diseases\n* Patients with alcohol abuse\n* Patients who smoke excessively\n* Patients with chronic inflammatory articular diseases such as rheumatoid arthritis\n* Patients who were enrolled in any other clinical trials within the past four weeks\n* Patients who had been administered with immunosuppressants such as Cyclosporin A or azathioprine within the past six weeks\n* Patients whose physical examination results show ligament instability of Grade II or above (Grade 0: none, Grade I: 0-5 mm, Grade II: 5-10 mm, Grade III: \\>10 mm)\n* Patients with a known history of hypersensitivity/allergy to gentamicin\n* Patients whom the principal investigator considers inappropriate for the clinical trial due to any other reasons than those listed above",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Hong-chul Lim, MD, PhD",
          "affiliation": "Korea University Guro Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Beom-gu Lee, MD, PhD",
          "affiliation": "Gachon University Gil Medical Center",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Jong-hyeok Choi, MD, PhD",
          "affiliation": "Gangnam Severance Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Hwa-jae Jeong, MD, PhD",
          "affiliation": "Kangbuk Samsung Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Chul-won Ha, MD, PhD",
          "affiliation": "Samsung Medical Center",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Jung-ro Yoon, MD, PhD",
          "affiliation": "Seoul Veterans Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Seong-il Bin, MD, PhD",
          "affiliation": "Asan Medical Center",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Jae-doo Yoo, MD, PhD",
          "affiliation": "Ewha Womans Mokdong Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Myung-ku Kim, MD, PhD",
          "affiliation": "Inha University Hospital",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Choong-hyuk Choi, MD, PhD",
          "affiliation": "Hanyang University",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Young-Chul Yoon, MD, PhD",
          "affiliation": "Samsung Medical Center",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Inha University Hospital",
          "city": "Incheon",
          "zip": "400-711",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.45646,
            "lon": 126.70515
          }
        },
        {
          "facility": "Gachon University Gil Hospital",
          "city": "Incheon",
          "zip": "405-760",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.45646,
            "lon": 126.70515
          }
        },
        {
          "facility": "Kangbuk Samsung Hospital",
          "city": "Seoul",
          "zip": "110-746",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Hanyang University Medical Center",
          "city": "Seoul",
          "zip": "133-792",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Seoul Veterans Hospital",
          "city": "Seoul",
          "zip": "134-060",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Samsung Medical Center",
          "city": "Seoul",
          "zip": "135-710",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Gangnam Severance Hospital",
          "city": "Seoul",
          "zip": "135-720",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center",
          "city": "Seoul",
          "zip": "138-736",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Korea University Guro Hospital",
          "city": "Seoul",
          "zip": "152-703",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Ewha Womans University Mokdong Hospital",
          "city": "Seoul",
          "zip": "158-710",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "33490296",
          "type": "DERIVED",
          "citation": "Lim HC, Park YB, Ha CW, Cole BJ, Lee BK, Jeong HJ, Kim MK, Bin SI, Choi CH, Choi CH, Yoo JD; Cartistem Research Group; Yoon JR, Chung JY. Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up. Orthop J Sports Med. 2021 Jan 12;9(1):2325967120973052. doi: 10.1177/2325967120973052. eCollection 2021 Jan."
        }
      ],
      "seeAlsoLinks": [
        {
          "label": "Study to Compare the Efficacy and Safety of Cartistem® and Microfracture in Patients With Knee Articular Cartilage Injury or Defect",
          "url": "http://clinicaltrials.gov/ct2/show/NCT01041001?term=cartistem&rank=1"
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "UNDECIDED"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2025-10-28"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D007592",
          "term": "Joint Diseases"
        },
        {
          "id": "D010003",
          "term": "Osteoarthritis"
        }
      ],
      "ancestors": [
        {
          "id": "D009140",
          "term": "Musculoskeletal Diseases"
        },
        {
          "id": "D001168",
          "term": "Arthritis"
        },
        {
          "id": "D012216",
          "term": "Rheumatic Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D054544",
          "term": "Arthroplasty, Subchondral"
        }
      ],
      "ancestors": [
        {
          "id": "D001178",
          "term": "Arthroplasty"
        },
        {
          "id": "D019637",
          "term": "Orthopedic Procedures"
        },
        {
          "id": "D013514",
          "term": "Surgical Procedures, Operative"
        },
        {
          "id": "D019651",
          "term": "Plastic Surgery Procedures"
        }
      ]
    }
  },
  "hasResults": false
}